Martin Shkreli wants you to punch him in the face. Literally.
I think important medicine should be expensive because they're valuable.
The former Turing Pharmaceuticals CEO made headlines by acquiring a drug used to treat HIV and increasing the price by 5,000 percent. He later defended Mylan, owners of the EpiPen, for raising the price of its drug used to treat severe allergic reactions.
Why the punch? Shkreli's friend, PR manager Mike Kulich, died of cancer on Saturday.
Is Mike Tyson free that afternoon?
Shkreli agreed to match the bids for a punch to his face "to a certain point" and will donate proceeds to a memorial fund for Kulich. So far, that fund has raised about $5,000, <b>according to its GiveForward page</b>.
Winners can also nominate someone else if they doubt their punching skills, <b>USA Today reports.</b>
A bidding war quickly escalated into five figures.
WATCH | For more news you need, check out our 60 Second Circa.